当前位置: X-MOL 学术CNS Neurosci. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
RGS16 promotes glioma progression and serves as a prognostic factor.
CNS Neuroscience & Therapeutics ( IF 5.5 ) Pub Date : 2020-04-22 , DOI: 10.1111/cns.13382
Ruoyu Huang 1, 2, 3 , Guanzhang Li 1, 2, 3 , Zheng Zhao 1, 3 , Fan Zeng 1, 3 , Kenan Zhang 1, 2, 3 , Yanwei Liu 3, 4 , Kuanyu Wang 3, 5 , Huimin Hu 1, 3
Affiliation  

RGS protein family members have recently became new potentially promising therapeutic targets in many cancers. However, as a key member of RGS family, RGS16 has seldom been studied in glioma. The present study was designed to investigate the prognostic value and biological function of RGS16 based on large‐scale databases and functional assays in vitro.

中文翻译:

RGS16 促进胶质瘤进展并作为预后因素。

RGS 蛋白家族成员最近已成为许多癌症中新的潜在有希望的治疗靶点。然而,作为RGS家族的重要成员,RGS16在胶质瘤中的研究很少。本研究旨在基于大规模数据库和体外功能测定研究 RGS16 的预后价值和生物学功能。
更新日期:2020-04-22
down
wechat
bug